LNSR Q1 2024 Earnings — LENSAR, Inc. Revenue & Financial Results | Market Cap Arena

LNSRLENSAR, Inc.

$142M

Q1 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$11M+28.3% YoY

Gross Profit

$5M50.9% margin

Operating Income

-$3M-26.9% margin

Net Income

-$2M-20.4% margin

EPS (Diluted)

$-0.19

QoQ Revenue Growth

-12.5%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$652,000

Balance Sheet

Total Assets

$66M

Total Liabilities

$34M

Stockholders' Equity

$32M

Cash & Equivalents

$14M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11M	$8M	+28.3%
Gross Profit	$5M	$4M	+24.8%
Operating Income	-$3M	-$4M	+34.6%
Net Income	-$2M	-$4M	+49.5%

Revenue Segments

Product

$7M86%

Service

$1M14%

Geographic Segments

UNITED STATES

$6M70%

Europe

$1M16%

Asia Excluding South Korea

$884,00010%

KOREA, REPUBLIC OF

$278,0003%

Other Geographical Region

$54,0001%